Skip to content

Evaluation of improvement of fatigue in the legs and feet

Evaluation of clinical efficacy and perceived improvement of fatigue in the legs and feet

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-2skhs4
Enrollment
Unknown
Registered
2015-05-08
Start date
2013-01-21
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic venous insufficiency

Interventions

38 patients between 12th and 30th week pregnancy should be applied 2 or 3 times a day, for 4 weeks, this lotion in legs and feet doing light massage. The evaluation will be done only intra-group, wit
Other
H02.010.625

Sponsors

Medcin Instituto da Pele
Lead Sponsor
Hospital Universitário Gaffrée e Guinle
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Pacients in the physiotherapy sector at the Gaffrée and Guinle University Hospital (HUGG); which have low back pain for more than three months; which have not undergone physiotherapy treatment in the last three months.

Exclusion criteria

Exclusion criteria: Patients who have a history of abdominal and lumbar surgery; infection; vertebral fracture; ankylosing spondylitis; cauda equine syndrome; cancer; radiculopathy in lumbar levels; lumbar stenosis; rheumatic syndromes and patients who receive some benefit labor.

Design outcomes

Primary

MeasureTime frame
Level of intensity of pain assessed through the numerical pain scale from the reduction of 50% in pre and post-intervention measurements.

Secondary

MeasureTime frame
Level of lumbar disability assessed through the Oswestry Disability Index from the reduction of 50% in pre and post-intervention measurements.

Countries

Brazil

Contacts

Public ContactLeandro Nogueira

Hospital Universitário Gaffrée e Guinle

leandro.nogueira@ifrj.edu.br+55(21)98797 5050

Outcome results

None listed

Source: REBEC (via WHO ICTRP)